Magenta Therapeutics (MGTA) stock forecast for 2024. Forecast tables and graphs.







Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…

Magenta Therapeutics (MGTA) stock forecast for 2024

Updated: May 18, 2024 (11:16)

Sector: Healthcare

The share price of Magenta Therapeutics, Inc. (MGTA) now

This company is DELISTED
What analysts predict: $
52-week High/Low: $ / $

50/200 Day Moving Average: $ / $

This figure corresponds to the Average Price over the previous 50/200 days. For Magenta Therapeutics stocks, the 50-day moving average is the support level today.

For Magenta Therapeutics stocks, the 200-day moving average is the support level today.

Are you interested in Magenta Therapeutics, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Magenta Therapeutics stock price in 2024. How much will one Magenta Therapeutics share be worth in 2024? Is it worth taking profit / loss on MGTA stock now or waiting? What are analysts' forecasts for Magenta Therapeutics stock?

We forecast Magenta Therapeutics stock performance using neural networks based on historical data on MGTA stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.

Magenta Therapeutics, Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.

The minimum target price for Magenta Therapeutics analysts is $. Today 200 Day Moving Average is the support level ( $). 50 Day Moving Average is the support level ( $).




Historical and forecast chart of Magenta Therapeutics, Inc. stock

The chart below shows the historical price of Magenta Therapeutics stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the MGTA stock price can be found in the table below.

No data

Magenta Therapeutics, Inc. is a clinical stage biotechnology company that develops new drugs for bone marrow transplantation. It offers a platform that focuses on critical areas of transplantation. The company was founded by David Scudden, Derrick Rossi, Alan Tyndall, Luigi Naldini, Robert Negrin, John F. Dipersio, and Jason Gardner in June 2015 and is headquartered in Cambridge, Massachusetts.

Magenta Therapeutics (MGTA) Forecast for 2024

Month Target Pes. Opt. Vol., %
Jun 0.71 0.65 0.74 13.06 %
Jul 0.69 0.67 0.76 11.50 %
Aug 0.74 0.71 0.77 7.26 %
Sep 0.70 0.66 0.77 14.69 %
Oct 0.65 0.60 0.69 12.71 %
Nov 0.66 0.61 0.71 14.26 %
Dec 0.64 0.60 0.70 14.54 %

Magenta Therapeutics information and performance

Magenta Therapeutics Address

N/A

Market Capitalization: N/A $

Market capitalization of the Magenta Therapeutics, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of MGTA shares in the company outstanding by the market price of one share.

EBITDA: N/A $

EBITDA of Magenta Therapeutics is earnings before interest, income tax and depreciation of assets.

PE Ratio: N/A

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: N/A

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: N/A

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: N/A

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: N/A

Enterprise Value (EV) /Revenue

EV To EBITDA: N/A

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: N/A

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

Magenta Therapeutics price target for 2024 by month


Target values for the price of one Magenta Therapeutics share for Jun 2024.

The weighted average target price per Magenta Therapeutics share in Jun 2024 is: 0.71.
In Jun, the Positive dynamics for Magenta Therapeutics, Inc. shares will prevail with possible monthly volatility of 13.056% volatility is expected.
Pessimistic target level: 0.65
Optimistic target level: 0.74

Target values for the price of one Magenta Therapeutics share for Jul 2024.

The weighted average target price per Magenta Therapeutics share in Jul 2024 is: 0.69.
In Jul, the Negative dynamics for Magenta Therapeutics, Inc. shares will prevail with possible monthly volatility of 11.503% volatility is expected.
Pessimistic target level: 0.67
Optimistic target level: 0.76

Target values for the price of one Magenta Therapeutics share for Aug 2024.

The weighted average target price per Magenta Therapeutics share in Aug 2024 is: 0.74.
In Aug, the Positive dynamics for Magenta Therapeutics, Inc. shares will prevail with possible monthly volatility of 7.257% volatility is expected.
Pessimistic target level: 0.71
Optimistic target level: 0.77

Target values for the price of one Magenta Therapeutics share for Sep 2024.

The weighted average target price per Magenta Therapeutics share in Sep 2024 is: 0.70.
In Sep, the Negative dynamics for Magenta Therapeutics, Inc. shares will prevail with possible monthly volatility of 14.688% volatility is expected.
Pessimistic target level: 0.66
Optimistic target level: 0.77

Target values for the price of one Magenta Therapeutics share for Oct 2024.

The weighted average target price per Magenta Therapeutics share in Oct 2024 is: 0.65.
In Oct, the Negative dynamics for Magenta Therapeutics, Inc. shares will prevail with possible monthly volatility of 12.710% volatility is expected.
Pessimistic target level: 0.60
Optimistic target level: 0.69

Target values for the price of one Magenta Therapeutics share for Nov 2024.

The weighted average target price per Magenta Therapeutics share in Nov 2024 is: 0.66.
In Nov, the Positive dynamics for Magenta Therapeutics, Inc. shares will prevail with possible monthly volatility of 14.264% volatility is expected.
Pessimistic target level: 0.61
Optimistic target level: 0.71

Target values for the price of one Magenta Therapeutics share for Dec 2024.

The weighted average target price per Magenta Therapeutics share in Dec 2024 is: 0.64.
In Dec, the Negative dynamics for Magenta Therapeutics, Inc. shares will prevail with possible monthly volatility of 14.535% volatility is expected.
Pessimistic target level: 0.60
Optimistic target level: 0.70



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.